Oximes: Novel therapeutics with anticancer and anti-inflammatory potential
IA Schepetkin, MB Plotnikov, AI Khlebnikov… - Biomolecules, 2021 - mdpi.com
Oximes have been studied for decades because of their significant roles as
acetylcholinesterase reactivators. Over the last twenty years, a large number of oximes have …
acetylcholinesterase reactivators. Over the last twenty years, a large number of oximes have …
Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship
H Wang, Z Wang, C Wei, J Wang, Y Xu, G Bai… - European Journal of …, 2021 - Elsevier
Indirubin is the crucial ingredient of Danggui Longhui Wan and Qing-Dai, traditional
Chinese medicine herbal formulas used for the therapy of chronic myelocytic leukemia in …
Chinese medicine herbal formulas used for the therapy of chronic myelocytic leukemia in …
Recent progress in the development of indole-based compounds active against malaria, trypanosomiasis and leishmaniasis
PAF Pacheco, MMM Santos - Molecules, 2022 - mdpi.com
Human protozoan diseases represent a serious health problem worldwide, affecting mainly
people in social and economic vulnerability. These diseases have attracted little investment …
people in social and economic vulnerability. These diseases have attracted little investment …
Indirubin and indirubin derivatives for counteracting proliferative diseases
T Blažević, EH Heiss, AG Atanasov… - Evidence‐Based …, 2015 - Wiley Online Library
Indirubin is the active component of Danggui Longhui Wan, a traditional Chinese medicine
formulation. The encouraging clinical results from the 1980s obtained in chronic myelocytic …
formulation. The encouraging clinical results from the 1980s obtained in chronic myelocytic …
Are the traditional medical uses of Muricidae molluscs substantiated by their pharmacological properties and bioactive compounds?
Marine molluscs from the family Muricidae hold great potential for development as a source
of therapeutically useful compounds. Traditionally known for the production of the ancient …
of therapeutically useful compounds. Traditionally known for the production of the ancient …
Design, synthesis, structure, in vitro cytotoxic activity evaluation and docking studies on target enzyme GSK-3β of new indirubin-3ʹ-oxime derivatives
NT Dan, HD Quang, V Van Truong, D Huu Nghi… - Scientific Reports, 2020 - nature.com
The addition of chalcone and amine components into indirubin-3′-oxime resulted in 15
new derivatives with high yields. Structures of new derivatives were also elucidated through …
new derivatives with high yields. Structures of new derivatives were also elucidated through …
6-bromo-indirubin-3′-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence …
AD Sklirou, N Gaboriaud-Kolar, I Papassideri… - Scientific Reports, 2017 - nature.com
As genetic interventions or extended caloric restriction cannot be applied in humans, many
studies have been devoted to the identification of natural products that can prolong …
studies have been devoted to the identification of natural products that can prolong …
Indirubin derivatives: A patent review (2010–present)
N Gaboriaud-Kolar, K Vougogiannopoulou… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Indirubins are bisindole alkaloids naturally occurring in indigo-bearing plants or
in mollusks from the Muricidae family. They belong to the rather small family of indigoids …
in mollusks from the Muricidae family. They belong to the rather small family of indigoids …
Recent progress in neuroactive marine natural products
R Sakai, GT Swanson - Natural product reports, 2014 - pubs.rsc.org
Covering: 1995 to early 2013 This review covers the isolation, chemical structure, biological
activity, structure activity relationships including synthesis of chemical probes, and …
activity, structure activity relationships including synthesis of chemical probes, and …
Drug delivery of 6-bromoindirubin-3'-glycerol-oxime ether employing poly(d,l-lactide-co-glycolide)-based nanoencapsulation techniques with sustainable solvents
A Czapka, C Grune, P Schädel, V Bachmann… - Journal of …, 2022 - Springer
Background Insufficient solubility and stability of bioactive small molecules as well as poor
biocompatibility may cause low bioavailability and are common obstacles in drug …
biocompatibility may cause low bioavailability and are common obstacles in drug …